logo
episode-header-image
Sep 2021
36m 4s

Diabetes Core Update SGLT2s and Diabetic...

AMERICAN DIABETES ASSOCIATION
About this episode

In this special episode on SGLT-2 inhibitors and CKD Drs. John Russell and Neil Skolnik discuss the effects of the SGLT-2 inhibitors in decreasing progression of chronic kidney disease.    This special episide is supported by independent educational grant from AstraZeneca.

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

  1. Background, Epidemiology, and Pathophysiology of Diabetic Kidney Disease
  2. ADA Recommendations for Screening and Diagnosis of Diabetic Kidney Disease
  • ADA Recommendations for Treatment of CKD in Persons with Diabetes
  1. Review of the Literature
    1. SGLT-2 inhibitor effects on CV and Kidney Outcomes in Patients with T2DM
    2. Dapagliflozin in Patients with Chronic Kidney Disease
    3. CKD Testing in Patients with T2DM
    4. Second-Line Therapy for T2DM Management: The Treatment/Benefit Paradox of CV and Kidney Comorbidities
    5. eGFR dip After Starting SGLT-2 inhibitors
    6. Dapagliflozin in patients with T2DM and Stages 3b–4 chronic kidney disease

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Up next
Yesterday
Special Edition: Treatment of Hypercortisolism in Uncontrolled Diabetes – July 2025
In this special episode on Treatment of Hypercortisolism in Uncontrolled Diabetes our host, Dr. Neil Skolnik, will discuss new evidence showing the surprising prevalence of Hypercortisolism in people with uncontrolled Type 2 Diabetes, and the effect of treatment. This special epi ... Show More
26m 59s
Jul 1
Diabetes Core Update July 2025
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximat ... Show More
30m 27s
Jun 12
Special Edition: Myth Busters - Fish Oil: Facts, Fiction, and EPA
In this special episode on Fish Oil - Facts, Fiction, and EPA our host, Dr. Neil Skolnik, will discuss the evidence distinguishing fish oil from EPA (Icosapent ethyl). This special episode is supported by an independent educational grant from Amarin. Presented by: Neil Skolnik, M ... Show More
22m 29s
Recommended Episodes
Aug 2022
S1 Episode 1: Chronic Kidney Disease and SGLT2 Inhibitors: Usage, Monitoring, and Possible Side Effects
Drs Sparks and Neuen discuss the proper use of SGLT2 inhibitors to prevent chronic kidney disease, including how to start them and monitor them and their possible side effects. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/vie ... Show More
24m 28s
May 2024
Diabetes and CKD: Strategies for Diagnosis and Treatment
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Ian de Boer, MD Since up to 40 percent of patients with diabetes develop diabetic kidney disease, it’s essential to know how to proactively diagnose and treat them using the latest therapeutic advances and strategies. T ... Show More
11 m
Jul 2023
S2 Episode 1: What's Your Approach? MRAs and Chronic Kidney Disease
Join experts Drs Matthew Sparks and James Matthew Luther as they discuss how and why they're using mineralocorticoid receptor antagonists to treat patients with diabetic kidney disease in their practice. Relevant disclosures can be found with the episode show notes on Medscape (h ... Show More
29m 53s
Aug 2019
Nephroprotektion durch SGLT-2-Inhibitoren
Revolution zur Behandlung chronischer Nierenerkrankungen? Studientelegramm 73-2019-3/3 Titel der Studie: Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Autoren: Perkovic et al. Journal: New England Journal of Medicine (NEJM) AMBOSS-Inhalte: Therapie der chron ... Show More
7m 36s
Aug 2021
USPSTF Recommendation: Screening for Prediabetes and Type 2 Diabetes
Interview with Chien-Wen Tseng, MD, USPSTF member and coauthor of Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. Related Content: Screening for Gestational Diabetes Screening for Prediabetes and Type 2 Diabetes Updated U ... Show More
16m 25s
Dec 2022
Dec 2, 2022 This Week in Cardiology Podcast
SGLT2 inhibitors, publishing choices, second and third order effects of interventions, decision support, and patient selection for preventive procedures are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. ... Show More
24 m
Apr 2022
#330 Inpatient Diabetes Part 1: Insulin regimens, oral hypoglycemics, corrections scales and more!
Dominate inpatient diabetes! In this part 1 of 2, we discuss how to handle oral hypoglycemics, how to choose an initial insulin regimen, the use of correction scale insulin monotherapy, how to titrate insulin, how to use NPH for steroid-induced hyperglycemia (check out this Twitt ... Show More
1h 20m
Feb 2024
Can type 2 diabetes really be reversed?
Today, we're breaking down a controversial question: can type 2 diabetes be reversed? There are tons of articles out there discussing this hot topic, but we dive into the evidence-based research behind it. Throughout this episode, we dissect the differences between prediabetes an ... Show More
18m 55s
Nov 2023
#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this “Ask Me Anything” (AMA) episode, Peter explores various pharmacologic tools commonly utilized to improve metabolic health and treat diabetes ... Show More
27m 10s
Jun 2024
INTERVIEW: The Evolution of Diabetes Treatment with Gary Taubes
View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman Sign Up for Dr. Hyman’s Weekly Longevity Journal Approximately 1.2 million Americans are diagnosed with diabetes each year​. Understanding the complex nature of this disease is crucial to tackling this w ... Show More
1h 34m